Revenue: The sum of all revenue fields included for a company's operating activities.
Gilead Sciences, Inc. (GILD) had Revenue of $7.08B for the most recently reported fiscal quarter, ending 2025-06-30.
Income Statement Financials | |
Revenue |
$7.08B |
$1.96B |
|
$1.50B |
|
$5.58B |
|
$4.61B |
|
$2.47B |
|
$-46.00M |
|
$2.43B |
|
$2.43B |
|
$1.96B |
|
$1.96B |
|
$1.96B |
|
$1.96B |
|
$2.47B |
|
$3.17B |
|
1.25B |
|
1.25B |
|
$1.57 |
|
$1.56 |
|
Balance Sheet Financials | |
$14.72B |
|
$5.46B |
|
$41.00B |
|
$55.72B |
|
$11.19B |
|
$22.14B |
|
$24.94B |
|
$36.13B |
|
$19.59B |
|
$-7.29B |
|
$19.59B |
|
1.24B |
|
Cash Flow Statement Financials | |
$2.58B |
|
$-2.53B |
|
$-4.99B |
|
$9.99B |
|
$5.14B |
|
$-4.85B |
|
$434.00M |
|
$-2.00B |
|
-- |
|
Fundamental Metrics & Ratios | |
1.32 |
|
-- |
|
-- |
|
0.53 |
|
1.27 |
|
78.81% |
|
34.93% |
|
34.93% |
|
-- |
|
34.30% |
|
27.68% |
|
$2.37B |
|
-- |
|
-- |
|
-- |
|
0.13 |
|
0.82 |
|
1.48 |
|
60.76 |
|
10.01% |
|
-26.90% |
|
3.52% |
|
4.70% |
|
$15.77 |
|
$1.89 |
|
$2.06 |